Although current pharmacological and behavioral treatments for obesity cause initial weight loss, this effect is transient and generally followed by weight regain, which is associated with leptin resistance (Yanovski and Yanovski, 2002). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.